Shares of Altamira Therapeutics (CYTO) have been struggling lately and have lost 16.6% over the past four weeks. However, a hammer chart pattern was formed in its last trading session, which could ...
Altamira Therapeutics Ltd. (NASDAQ:CYTO) shares are trading higher Thursday after the company announced highlights from its NASAR clinical trial with Bentrio nasal spray were published in video format ...
FORT COLLINS, Colo., Feb. 16, 2021 /PRNewswire/ -- Cytocom, Inc., a leading biopharmaceutical company creating first second-generation immune therapies, today provided an update regarding its CYTO-200 ...
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...
Cyto-Mine® can simplify and accelerate your day-to-day operations in cell line development, antibody discovery, and beyond. It’s powered by our picodroplet technology to screen and analyze millions of ...
Sphere Bio, a leading provider of innovative picodroplet-based microfluidics solutions for functional single-cell analysis and isolation, today announced the launch of the Cyto-Cellect® Human IgG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results